Hepatitis C revealed during covid-19 infection. A case report

SARS-CoV-2 coronavirus was discovered by the end of December 2019, in Wuhan, China; more than 135 million people have been infected and more than 2.9 millions have died worldwide. The COVID-19 pandemic is an ongoing public health emergency. Patients with chronic diseases are at major risk of complications and poor prognosis. We present here a case of hepatitis C discovered during COVID-19 pandemic, highlighting the epidemiological, diagnostic and therapeutic issues surrounding this co-infection. The aim of this case study was to evaluate liver function abnormalities and the relationship between COVID-19 severity and progression of liver disease. Our male patient had a medical history of stroke. He presented with symptoms of COVID-19 in July 2021 : chills and a progressive and significant biological disturbance: disturbed liver function tests, elevated CRP and severe thrombocytopenia at blood count formula. General condition rapidly worsened with desaturation. The first chest CT revealed interstitial lung disease compatible with covid involvement. After the failure of several therapeutic approaches, and in view of the worsening general condition and persistent biological disturbance, especially in the presence of signs pointing to liver damage, HCV serology and viral load were requested and found to be positive. The patient was stabilized for his COVID-19 infection, then began antiviral treatment for hepatitis C. Progression was spectacular within three months.